Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
International Discovery Service Unit (IDSU)
Research Service Division (RSD)Enabling Unbounded Possibilities
Global Leader in Discovery Chemistry OutsourcingService Based on FTE (Full Time Equivalent) Model
Bringing Capabilities, Capacities andValue to Meet Drug Discovery Needs.
http://rsd.wuxiapptec.com
Our Special Chemistry 1
Broad Capability to Speed up Your Drug Discovery
Antibody Drug Conjugates Oligonucleotide
Photoredox Chemistry Flow Chemistry
Fluorine Chemistry Carbohydrate Chemistry
Peptide Chemistry Nucleoside & Nucleotide Chemistry
Computational Chemistry Natural Product and Metabolites
Organometallic Compound and Ligand Synthesis Catalyst Screening
Our Special Chemistry 2Comprehensive Expertise in Chemistry to Support Your Research
Bio-catalysis Electrochemistry
Focused Library AI & QM Synthesis Design
Boron Chemistry PROTAC
Covalent Inhibitors Deuterated Compounds
Unnatural Amino Acid Late Stage Functionalization
Discovery Process Chemistry Medicinal Chemistry Design
Contact Declan Ryan (US)Vice President, Business [email protected]
Dave Madge (Europe)Vice President, Business Development [email protected]
Yan Zhu (Japan)Executive Director, Business [email protected]
Research Service Division (RSD)Enabling Unbounded Possibilities
Suk Young Cho (Korea)Executive Director, Business [email protected]
International Discovery Service Unit (IDSU)
A Global Resource for Small Molecule Research & Development
IDSU
TargetTo Hit
HitTo Lead
Lead Optimization Phase I Phase IIIPhase II Submission
& LaunchPreclinical
Enable Discovery Stage of Drug Research
IDSU LocationsTianjin SiteOperation since 2006
Shanghai North SiteOperation since 2019
Shanghai Site R&D HeadquartersOperation since 2001
Operation since 2012Wuhan Site
Chengdu SiteOperation since 2020
San Francisco Bay Area SiteOperation since 2020
WuXi AppTecSan Francisco Bay
Area Research Service
3800+synthetic and medicinal chemists
Customization to Client’s Needs
6 5 sites in China: Shanghai, Tianjin, Wuhan, Shanghai North and Chengdu1 site in US San Francisco Bay Area
290+ clients around the world
162000+compounds delivered in 2019
24patents in 2019
23scientific publications in 2019
24pre-clinical candidates delivered in 2019
2FDA-approved drugs from WuXi integrated platform
Project Management
Medicinal Chemistry
Provide compound design and project management
Integrated Projects
From targets to hits to leads to preclinical candidates
Manage project timelines and compound flow
Synthetic Chemistry
High productivity, quality, speed, and reliability